2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Five-Year PYTHAGORAS Data Presented for Lombard Medical's Aorfix EVAR System

December 5, 2016 -- Lombard Medical, Inc. announced that long-term data for its Aorfix endovascular stent graft system were presented on November 17 at the 43rd annual VEITHsy…

Teleflex to Acquire Vascular Solutions

December 2, 2016 -- Teleflex Incorporated and Vascular Solutions, Inc. announced that the companies have entered into a definitive agreement under which Teleflex will acquire …

Study Supports Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

December 1, 2016 -- A prospective, multicenter, observational study evaluated the safety and effectiveness of tibiopedal access and retrograde crossing in the treatment o…

Gore Announces 2016 Pioneers in Performance for North America

November 29, 2016 -- Gore & Associates recently announced the biennial Pioneers in Performance awards for five North American physicians, acknowledging their exceptional w…

Study Compares Thresholds for AAA Repair in England and the United States

November 30, 2016 -- Findings from an evaluation of the thresholds for abdominal aortic aneurysm (AAA) repair in England and the United States were published by Alan Kart…

SVIN Announces Worldwide Effort to Increase Use of Mechanical Thrombectomy for Stroke

November 30, 2016 -- The Society of Vascular and Interventional Neurology (SVIN) recently announced the launch of Mission Thrombectomy 2020, an initiative to enhance global ef…

Click here for more News coverage

Current Supplement

Sponsored by BOLTON MEDICAL

Ahead of the Curve

Current European Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

RevELUTIONizing Drug-Eluting Technologies

How drug-eluting therapies are shaping a new era of endovascular interventions.

Featured Video

Sponsored by Intact Vascular

Addressing Post-PTA Dissections with a Unique and Novel Approach

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $38.43  1.40%
AstraZeneca PLC $25.82  -0.29%
Avinger $3.95  0.00%
Boston Scientific Corporation $20.71  1.77%
Cardinal Health $72.10  1.79%
Cardiovascular Systems Inc. $23.85  1.97%
CR Bard Inc. $210.21  0.12%
Edwards Lifesciences Corp. $82.49  -0.99%
Endologix Inc. $7.00  -0.71%
Johnson and Johnson $111.94  -0.01%
Vascular Market Price  Change
Lombard Medical, Inc. $0.78  -0.01%
Medtronic, Inc. $71.67  -0.49%
Merit Medical Systems, Inc. $24.75  0.61%
Penumbra, Inc. $61.30  3.90%
St. Jude Medical Inc. $79.49  0.59%
Stryker $112.01  -0.06%
The Medicines Company $34.48  3.17%
The Spectranetics Corporation $22.90  2.92%
Vascular Solutions Inc. $55.90  -0.18%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.